TSS
CAPR icon

Two Sigma Securities’s Capricor Therapeutics CAPR Stock Holding History

Two Sigma Securities’s Portfolio CAPR Stock Details CAPR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-9,466
Closed -$288K – 1779
2026
Q1 		$288K Buy
+9,466
New +$252K 0.03% 803
2024
Q4 		– Sell
-17,139
Closed -$261K – 1829
2024
Q3 		$261K Buy
+17,139
New +$84.8K ﹤0.01% 1908
2021
Q4 		– Sell
-11,511
Closed -$46K – 1579
2021
Q3 		$46K Buy
+11,511
New +$52.4K ﹤0.01% 1391
2017
Q4 		– Sell
-2,559
Closed -$78K – 1733
2017
Q3 		$78K Buy
+2,559
New +$30.6K 0.01% 698

Other funds holding CAPR

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
BCM
Boxer Capital Management San Diego, California $1.33B AUM 864.5% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Two Sigma Securities's CAPR Position: Q2 2026 in Review

Two Sigma Securities sold out of Capricor Therapeutics (CAPR) in Q2 2026, closing a stake of 9,466 shares — an estimated $288K sold.

Two Sigma Securities first reported a position in CAPR in Q3 2017 and held it in 4 quarters. The position peaked at $288K in Q1 2026. 170 funds tracked by Wall St. Rank hold CAPR as of Q2 2026.

  • Two Sigma Securities reported no remaining Capricor Therapeutics position as of Q2 2026 after selling out during the quarter.
  • Two Sigma Securities sold 9,466 Capricor Therapeutics shares in Q2 2026, an estimated $288K.
  • Two Sigma Securities first reported a position in Capricor Therapeutics in Q3 2017 and held it in 4 quarters.
  • Two Sigma Securities's Capricor Therapeutics position peaked at $288K in Q1 2026.
  • 170 funds tracked by Wall St. Rank held Capricor Therapeutics as of Q2 2026.

Based on Two Sigma Securities's 13F filing for Q2 2026, filed 14 Aug 2026.